Trans Genic Inc.
2342.T
Price:
$283
Market Cap:
$4.71B
Trans Genic Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment Business segments. The company provides glycan synthesis and analysis services; non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods, and pharmaceutical agents; and support for bioequivalence test, including clinical trials, pharmacokinetic measurements, and the preparation of clinical trial reports; as well as hospital support services. It also offers drug efficiency and pharmacological test and safety studies; sugar chain analysis and synthesis...[Read more]
Industry
Biotechnology
IPO Date
2002-12-10
Stock Exchange
JPX
Ticker
2342.T
PE Ratio
[-5.36]
ROE
[-18.55%]
Current Ratio
[1.94]
Dividend Yield
[0%]
Enterprise Value
[5.26B]
Dividend History
The ROE as of December 2025 (TTM) for Trans Genic Inc. (2342.T) is -18.55%
According to Trans Genic Inc.’s latest financial reports and current stock price. The company's current ROE is -18.55%. This represents a change of 278.16% compared to the average of -4.90% of the last 4 quarters.
Trans Genic Inc. (2342.T) Historical ROE (quarterly & annually)
How has 2342.T ROE performed in the past?
The mean historical ROE of Trans Genic Inc. over the last ten years is 0.04%. The current -18.55% ROE has changed -44085.07% with respect to the historical average. Over the past ten years (40 quarters), 2342.T's ROE was at its highest in in the December 2022 quarter at 1.92%. The ROE was at its lowest in in the March 2025 quarter at -16.75%.
Average
0.04%
Median
-3.37%
Minimum
-22.88%
Maximum
28.72%
Trans Genic Inc. (2342.T) ROE by Quarter and Year
Discovering the peaks and valleys of Trans Genic Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 158.49%
Maximum Annual ROE = 28.72%
Minimum Annual Increase = -33110.61%
Minimum Annual ROE = -22.88%
| Year | ROE | Change |
|---|---|---|
| 2025 | -22.88% | -33110.61% |
| 2024 | 0.07% | -101.02% |
| 2023 | -6.81% | -123.70% |
| 2022 | 28.72% | 158.49% |
| 2021 | 11.11% | -211.52% |
Trans Genic Inc. (2342.T) Average ROE
How has 2342.T ROE performed in the past?
The current ROE of Trans Genic Inc. (2342.T) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-9.87%
5-year avg
2.04%
10-year avg
0.04%
Trans Genic Inc. (2342.T) ROE vs. Peers
How is 2342.T’s ROE compared to its peers?
Trans Genic Inc.’s ROE is greater than Kubota Pharmaceutical Holdings Co., Ltd. (-82.75%), greater than Kringle Pharma, Inc. (-55.80%), greater than FunPep Company Limited (-55.89%), greater than Ribomic Inc. (-32.41%), greater than Carna Biosciences, Inc. (-101.01%), greater than PhoenixBio Co., Ltd. (-29.46%), less than FB Care Service Co.,Ltd. (11.69%), greater than Delta-Fly Pharma, Inc. (-328.10%), less than internet infinity Inc. (14.20%), less than Miahelsa Holdings Corporation (7.61%),
| Company | ROE | Market cap |
|---|---|---|
| -82.75% | $3.00B | |
| -55.80% | $2.68B | |
| -55.89% | $3.49B | |
| -32.41% | $3.64B | |
| -101.01% | $4.60B | |
| -29.46% | $2.19B | |
| 11.69% | $3.03B | |
| -328.10% | $5.91B | |
| 14.20% | $3.31B | |
| 7.61% | $3.16B |
Build a custom stock screener for Trans Genic Inc. (2342.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trans Genic Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Trans Genic Inc. (2342.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Trans Genic Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Trans Genic Inc.'s ROE?
How is the ROE calculated for Trans Genic Inc. (2342.T)?
What is the highest ROE for Trans Genic Inc. (2342.T)?
What is the 3-year average ROE for Trans Genic Inc. (2342.T)?
What is the 5-year average ROE for Trans Genic Inc. (2342.T)?
How does the current ROE for Trans Genic Inc. (2342.T) compare to its historical average?